Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cytometry. Part B, Clinical Cytometry|May 31, 2024
Synthetic abnormal mast cell particles successfully mimic neoplastic mast cells by flow cytometryPatricia M Davis, Eugene Ravkov, Martina de Geus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2015
A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast CancerCynthia X Ma, Jingqin Luo, Michael Naughton, et al.
JCO Clinical Cancer Informatics|October 17, 2019
Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion ProbesErica K Barnell, Adam Waalkes, Matt C Mosior, et al.
Microbiology Spectrum|June 23, 2025
Use of a convolutional neural network for direct detection of acid-fast bacilli from clinical specimensPaul English, Muir J Morrison, Blaine Mathison, et al.
Communications Biology|July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalEmilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2018
Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samplesErica K Barnell, Peter Ronning, Katie M Campbell, et al.
Nature Methods|October 15, 2013
DGIdb: mining the druggable genomeMalachi Griffith, Obi L Griffith, Adam C Coffman, et al.
Genome Medicine|November 30, 2019
Standard operating procedure for curation and clinical interpretation of variants in cancerArpad M Danos, Kilannin Krysiak, Erica K Barnell, et al.
Science Translational Medicine|July 19, 2023
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicityErica R Vander Mause, Jillian M Baker, Kenneth A Dietze, et al.
Blood Advances|October 17, 2022
Distinct clonal identities of B-ALLs arising after lenolidomide therapy for multiple myelomaErica K Barnell, Zachary L Skidmore, Kenneth F Newcomer, et al.
Pageof 5